| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.37B | 81.70B | 69.56B | 67.95B | 70.47B | 66.78B |
| Gross Profit | 13.63B | 15.98B | 12.01B | 10.81B | 11.62B | 10.96B |
| EBITDA | 7.55B | 5.89B | 5.46B | 4.43B | 5.29B | 5.03B |
| Net Income | 3.18B | 4.46B | 2.20B | 2.01B | 2.17B | 2.06B |
Balance Sheet | ||||||
| Total Assets | 55.99B | 71.17B | 64.15B | 55.25B | 56.13B | 51.90B |
| Cash, Cash Equivalents and Short-Term Investments | 7.84B | 10.43B | 10.39B | 10.99B | 9.80B | 9.29B |
| Total Debt | 4.14B | 16.05B | 11.98B | 5.39B | 6.38B | 3.95B |
| Total Liabilities | 21.49B | 32.63B | 29.47B | 21.98B | 24.28B | 21.55B |
| Stockholders Equity | 34.05B | 38.08B | 34.22B | 32.82B | 31.42B | 29.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.99B | -6.44B | 3.72B | -1.02B | -2.85B |
| Operating Cash Flow | 0.00 | -2.36B | 621.00M | 7.07B | 560.00M | -1.03B |
| Investing Cash Flow | 0.00 | -1.29B | -6.50B | -3.63B | -1.29B | -2.09B |
| Financing Cash Flow | 0.00 | 3.65B | 5.33B | -2.26B | 1.20B | 502.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥46.41B | 11.14 | ― | 3.78% | 24.67% | 72.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥41.66B | 9.30 | ― | 2.26% | 17.46% | 102.48% | |
62 Neutral | ¥60.01B | 10.49 | ― | 0.79% | 0.81% | -53.76% | |
60 Neutral | ¥61.81B | 14.53 | ― | 1.57% | 4.01% | 21.41% | |
58 Neutral | ¥68.43B | 12.71 | ― | 2.73% | -2.86% | 50.42% | |
54 Neutral | ¥43.36B | 9.90 | ― | 2.84% | 21.15% | 18.25% |